TKH GROUPNV CVA financials
TKH GROUPNV CVA
7245008G22FOV7TYYJ34 ISIN: NL0000852523 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €1.76B | €1.71B |
| Operating expenses | €1.66B | €1.58B |
| Employee benefits expense | €487.4M | €477.6M |
| Depreciation & amortisation | €61.0M | €60.8M |
| Operating profit (EBIT) | €103.0M | €130.6M |
| Finance costs | €29.7M | €30.7M |
| Profit before tax | €111.1M | €123.5M |
| Income tax expense | €16.8M | €24.0M |
| Profit for the year | €94.3M | €99.5M |
| — attributable to owners | €94.4M | €99.6M |
| — attributable to NCI | -€73.0K | -€30.0K |
| Total comprehensive income | €73.8M | €110.5M |
| Per share | ||
| Basic EPS | €2.37 | €2.50 |
| Diluted EPS | €2.37 | €2.50 |
| Free cash flow / share | €3.07 | €2.40 |
| Cash flow statement | ||
| Cash generated from operations | €234.2M | €269.6M |
| Net cash from operating activities | €192.4M | €196.2M |
| Income taxes paid | €13.0M | €45.3M |
| Net cash from investing activities | -€74.7M | -€138.8M |
| Purchase of PP&E (capex) | €70.1M | €100.7M |
| Purchase of intangibles | €60.2M | €61.7M |
| Net cash from financing activities | -€113.3M | -€24.1M |
| Dividends paid | €59.9M | €67.9M |
| Lease liability payments | €17.2M | €16.0M |
| Net change in cash | €4.4M | €33.3M |
| Balance sheet | ||
| Total assets | €2.15B | €2.21B |
| Non-current assets | €1.22B | €1.22B |
| Property, plant & equipment | €501.1M | €486.2M |
| Right-of-use assets | €77.8M | €78.0M |
| Intangible assets & goodwill | €597.7M | €611.1M |
| Inventories | €342.3M | €398.6M |
| Trade & other receivables | €253.5M | €250.0M |
| Cash & equivalents | €125.3M | €125.6M |
| Total equity | €899.9M | €883.1M |
| — attributable to owners | €899.8M | €883.0M |
| Non-controlling interests | €83.0K | €108.0K |
| Non-current liabilities | €636.8M | €699.1M |
| Trade & other payables | €341.9M | €327.7M |
| Deferred tax liabilities | €53.8M | €59.0M |
| Derived metrics | ||
| Free cash flow | €122.3M | €95.5M |
| Operating margin | 5.8% | 7.6% |
| Net margin | 5.4% | 5.8% |
| Return on equity | 10.5% | 11.3% |
| Cash conversion ratio | 2.04× | 1.97× |
| Capex coverage | 2.74× | 1.95× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €130.4M | €121.7M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€157.0K | -€337.0K |
| Adjustments For Provisions | -€2.8M | -€14.0K |
| Adjustments For Sharebased Payments | €3.8M | €3.8M |
| Assets Recognised From Costs To Obtain Or Fulfil Contracts With Customers | €5.5M | €10.3M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €125.3M | €127.3M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €21.6M | €15.8M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €38.6M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €214.0K | -€90.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | -€90.0K | -€40.0K |
| Comprehensive Income Attributable To Owners of Parent | €73.9M | €110.6M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €930.7M | €963.4M |
| Current Contract Assets | €198.5M | €165.9M |
| Current Contract Liabilities | €137.6M | €176.6M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €615.6M | €622.2M |
| Current Provisions | €16.2M | €19.8M |
| Current Tax Assets Current | €5.6M | €12.9M |
| Current Tax Liabilities Current | €8.2M | €5.8M |
| Deferred Tax Assets | €16.8M | €16.9M |
| Dividends Received From Associates Classified As Investing Activities | €30.0K | €60.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€6.4M | €256.0K |
| Equity and Liabilities | €2.15B | €2.21B |
| Finance Income | €1.3M | €1.4M |
| Gains Losses On Disposals of Investments | €35.8M | €24.2M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | €1.4M | -€3.0M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €8.7M | €8.5M |
| Increase Decrease In Cash and Cash Equivalents | -€2.0M | €33.5M |
| Increase Decrease In Working Capital | €32.0K | -€13.9M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €3.8M | €3.8M |
| Interest Paid Classified As Operating Activities | €30.2M | €29.5M |
| Interest Received Classified As Operating Activities | €1.3M | €1.4M |
| Investments In Associates Accounted For Using Equity Method | €27.7M | €29.7M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €9.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €27.2M |
| Noncurrent Provisions | €11.8M | €13.1M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €2.6M | €3.1M |
| Other Comprehensive Income | -€20.5M | €11.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €5.5M | -€1.4M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€103.0K | -€234.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€20.4M | €11.2M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€103.0K | -€234.0K |
| Other Current Financial Liabilities | €1.8M | €1.9M |
| Other Expense By Nature | €166.6M | €159.0M |
| Other Noncurrent Financial Liabilities | €3.0M | €3.8M |
| Other Noncurrent Receivables | €628.0K | €842.0K |
| Proceeds From Noncurrent Borrowings | €75.0M | €44.1M |
| Proceeds From Sale Or Issue of Treasury Shares | €93.0K | €3.0M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €116.0K | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.1M | €2.0M |
| Repayments of Noncurrent Borrowings | €130.8M | €0 |
| Sale Or Issue of Treasury Shares | €93.0K | €3.0M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | -€1.6M | €249.0K |
Every line item above is a fact tagged in TKH GROUPNV CVA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.